Halozyme Therapeutics, Inc. (HALO)
81.23
+2.81
(+3.58%)
USD |
NASDAQ |
Feb 06, 16:00
81.99
+0.76
(+0.94%)
After-Hours: 20:00
Halozyme Therapeutics Price : 81.23 for Feb. 6, 2026
Price Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Price Definition
The price of a security measures the cost to purchase 1 share of a security. For a company, price can be multiplied by shares outstanding to find the market capitalization (value of the company).
Price Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price Benchmarks
| Johnson & Johnson | 239.99 |
| Merck & Co., Inc. | 121.93 |
| AIM ImmunoTech, Inc. | 1.14 |
| Stryker Corp. | 358.29 |
| Skye Bioscience, Inc. | 0.8193 |
Price Related Metrics
| PE Ratio | 17.07 |
| PS Ratio | 8.204 |
| PEG Ratio | 0.2973 |
| Price to Book Value | 18.96 |
| Price to Free Cash Flow | 16.93 |
| Earnings Yield | 5.86% |
| Market Cap | 9.552B |
| PEGY Ratio | 0.2973 |
| Operating PE Ratio | 13.83 |
| Normalized PE Ratio | 17.07 |